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Enterohemorrhagic Escherichia coli (EHEC) 0157:H7 is a food-borne
pathogen that can cause bloody diarrhea and, occasionally, acute
renal failure as a consequence of Shiga toxin (Stx) production by
the organism. Stxs are potent cytotoxins that are lethal to animals
at low doses. Thus, Stxs not only harm the host but, as reported
here, also significantly enhance the capacity of EHEC O157:H7 to
adhere to epithelial cells and to colonize the intestines of mice.
Tissue culture experiments showed that this toxin-mediated in-
crease in bacterial adherence correlated with an Stx-evoked in-
crease in a eukaryotic receptor for the EHEC O157:H7 attachment
factor intimin.
adherence  nucleolin
Enterohemorrhagic Escherichia coli (EHEC) are commensalbacteria of cattle that can cause serious disease in humans who
come in direct contact with the animals or who ingest undercooked
ground beef or cowmanure-contaminated water, cider, vegetables,
or other products (1). The disease presents as mild diarrhea,
hemorrhagic colitis, or, in a subset of patients, a sequela called the
hemolytic uremic syndrome (HUS) that is characterized by throm-
bocytopenia, hemolytic anemia, and kidney lesions (2). Indeed,
EHEC serotype O157:H7, which is a member of a larger group of
Shiga toxin (Stx)-producing E. coli (STEC), is estimated to cause
73,000 cases of disease per year in theUnited States (3) and is the
most frequent cause of acute renal failure in children in the United
States (2). Stxs are responsible forHUS (4) and are categorized into
two antigenically distinct groups, Stx1 and Stx2 (5). Stxs are potent
cytotoxins that are composed of a single A polypeptide and five B
polypeptides. The toxins are internalized by clathrin-dependent
endocytosis after binding of the B pentamer to the target cell
glycolipid receptor globotriaosylceramide (Gb3) (5). The A
polypeptide of the toxins is an N-glycosidase that removes a single
adenine from the 28S eukaryotic rRNA and inhibits protein
synthesis in susceptible cells (5). Although the production of Stxs by
STEC is correlated with pathology in the host, identification of a
mechanism by which Stx, or, for that matter, any bacterial toxin, is
of direct benefit to the survival of the bacterium has eluded
microbiologists.
One possible connection between toxin production and EHEC
O157:H7 persistence might relate to how the organism is main-
tained in the gut. Colonization of the large intestine by EHEC
O157:H7 results in an ‘‘attaching-and-effacing’’ lesion character-
ized by an actin-rich pedestal formed by the host cell around the
bacteria, destruction of brush border microvilli, and intimate ad-
hesion of the pathogen to the enterocyte surface (6, 7). Two
bacterial genes expressed from a chromosomal pathogenicity island
termed the locus for enterocyte effacement (LEE) contribute to
this pattern of adherence. Intimin, the protein product of the eae
gene, is a major outer membrane surface adhesin (8). The trans-
located intimin receptor (Tir) is a transmembrane protein secreted
through the type III secretion system of the LEE locus that is
inserted into the host cell membrane to serve as a receptor for
intimin (6, 7).
We previously reported that intimin recognizes not only the
bacterially encodedTir as a receptor but also the eukaryotic protein
nucleolin localized on the surface of tissue culture cells (9). Nucleo-
lin is a multifunctional protein that is present in abundance in the
nucleus and primarily functions in ribosome biogenesis. However,
nucleolin can be expressed at the cell surface inmany cell types (10)
and serves as a receptor for some viruses (11, 12). In our earlier
study (9), we demonstrated that (i) intimin interacts with nucleolin
that is present in HEp-2 cell extracts, (ii) purified intimin and
nucleolin colocalize on the surface of HEp-2 cells, (iii) the sites of
EHEC O157:H7 microcolonies coincide with regions of surface-
expressed nucleolin, and (iv) anti-nucleolin serum reduces EHEC
O157:H7 adherence when added before or at the time of infection.
We hypothesized that Stx produced during infection may promote
increased adherence of EHEC O157:H7 to enterocytes and, con-
sequently, colonization of the bowel by enhancing cell surface
expression of nucleolin.
Results
Comparison of Growth, Protein Expression, and Cytotoxicity. Strain
86-24 is a clinical isolate of EHEC O157:H7 that produces Stx2.
EHEC O157:H7 strain TUV86-2, an isogenic stx2 mutant, was
constructed (13) and kindly provided by A. Donohue-Rolfe (Tufts
University, North Grafton, MA). These strains were used to
compare levels of adherence to HEp-2 epithelial cells in culture [an
established model for evaluating adherence of EHEC O157:H7
(14)] and colonization of mice. Before these assays, we conducted
comparative analyses of the relevant properties of the two strains.
We found that the growth rates of 86-24 and TUV86-2 in minimal
or rich culture media were indistinguishable (Fig. 1A) and that Stx2
was detectable by immunoblot in lysates of 86-24 but not TUV86-2
(Fig. 1B). We also noted Vero cell cytotoxic activity in association
with the 86-24 lysates (50% cytotoxic dose  4  106 per ml) but
not the TUV86-2 lysates (Fig. 1C). The finding that lysates of strain
TUV86-2 were not toxic for Vero cells is solely attributable to the
deleted sequence in the stx2 operon and not the absence of the
bacteriophage (see Fig. 5 and Supporting Text, which are published
as supporting information on the PNAS web site). Additionally, we
compared Tir and intimin expression levels in 86-24 and TUV86-2
by immunoblot and found them to be comparable for both proteins
(Fig. 1B).
Stx2 Contributes to Increased Adherence to Epithelial Cells in Culture.
Next, we compared the pattern of adherence to HEp-2 cells by
86-24 and TUV86-2; each strain expressed GFP equivalently from
a plasmid (data not shown). As expected, both strains adhered to
HEp-2 cells under standard conditions and exhibited a typical
localized pattern of adherence that is characteristic of attaching-
and-effacing lesions, including microcolony formation and con-
densed actin staining (see Fig. 6, which is published as supporting
information on the PNAS web site). However, microcolony for-
mation appeared to be less pronounced for TUV86-2 than for 86-24
Conflict of interest statement: No conflicts declared.
This paper was submitted directly (Track II) to the PNAS office.
Freely available online through the PNAS open access option.
Abbreviations: EHEC, enterohemorrhagic Escherichia coli; cfu, colony-forming units; Stx,
Shiga toxin; Tir, translocated intimin receptor.
*To whom correspondence should be addressed. E-mail: aobrien@usuhs.mil.
www.pnas.orgcgidoi10.1073pnas.0602359103 PNAS  June 20, 2006  vol. 103  no. 25  9667–9672
M
IC
RO
BI
O
LO
G
Y
(Fig. 6). These observations prompted us to analyze adherence of
the GFP-expressing strains to HEp-2 cells by a quantitative flow
cytometric assay. Those epithelial cells to which bacteria adhered
exhibited green fluorescence. The intensity of fluorescence was
considered reflective of the number of adhered bacteria per
epithelial cell and thus the magnitude of microcolony formation.
The percentage of HEp-2 cells infected with TUV86-2 was mod-
estly (15%) but significantly (P 0.003) reduced compared with
cells infected with the WT 86-24 (Fig. 2A). Additionally, there was
a nearly 40% decrease (P  0.001; Fig. 2A) in microcolony
formation of the population infected with TUV86-2. These quan-
titative adherence results suggest that Stx2 production provides an
advantage to 86-24 by increasing the organism’s capacity to adhere
to cells.
Because Stx2 was produced by 86-24 under conditions of the
adherence assay (see Fig. 7, which is published as supporting
information on the PNAS web site) and could account for the
difference exhibited between 86-24 and TUV86-2, we investigated
whether the presence of Stx2 during TUV86-2 adherence could
restore adherence toWT levels. Governmental restrictions prevent
complementation of stx2 genes by recombinant techniques, so
purified Stx2 was added to HEp-2 cells 2 h before infection. The
presence of Stx2 before and during 6 h of infection fully restored
adherence of infected epithelial cells to levels equivalent to or
greater than those obtained with 86-24 (Fig. 2A). The addition of
anti-Stx2 neutralizing mAb BC5 to the Stx2-containing media
returned levels of TUV86-2 adherence to those observed in the
absence of toxin, but the presence of normal mouse serum did not
abrogate the effects of Stx2 (Fig. 2A). In a separate experiment, we
investigated the effect on adherence of an E167D mutation in the
Stx2 active site (15) that reduced cytotoxic activity 1,000-fold (see
Fig. 8, which is published as supporting information on the PNAS
web site). This mutant toxin did not increase adherence of
TUV86-2 (Fig. 2B). These results indicate that the presence of Stx2
can specifically complement the toxin-negative TUV86-2 strain for
the capacity to adhere to epithelial cells at a level comparable to the
WT strain and that the enzymatic activity of the toxin is required
for this effect.
Stx2 Production Enhances Colonization of Mice.We then investigated
whether production of Stx2 by strain 86-24 affected the colonization
of BALBc mice. A significant difference in colonization [geomet-
ric mean colony-forming units (cfu)ml per g of feces] between
strains 86-24- and TUV86-2-infected animals was evident by day 3
after infection (Fig. 3A). This difference in colonization was
maintained through day 7, and an overall significant difference
between strains for all days studied was exhibited (P  0.004).
Next, we consideredwhether 86-24 could out-compete TUV86-2
in a mixed infection. To address this possibility, mice were orally
infected with an equal ratio of 86-24 and TUV86-2. There was no
significant difference in colonization between strains (P  0.69).
These results suggest that Stx2 production by 86-24 enhances
TUV86-2 colonization in a mixed-strain infection. This contention
is further supported by the observation that, on some days, the level
of colonization of TUV86-2 was increased by more than one order
of magnitude compared with the single-strain infections (Fig. 3B).
Furthermore, these results are consistent with in vitro adherence
results (Fig. 2).
Stx2 Increases Nucleolin Surface Expression on Epithelial Cells in
Culture. Previous unpublished work from our laboratory suggested
that exposure of epithelial cells to Stx1 and Stx2 resulted in an
increase in surface-expressed nucleolin. This increase should, in
theory, provide a greater number of receptors available for EHEC
attachment before the translocation of Tir. Therefore, we quanti-
fied the amount of nucleolin on the surface ofHEp-2 cells over time
in response to treatment with increasing concentrations of purified
Stx2. Our immunodetection method was limited to the cell surface,
as indicated by the lack of significant surface labeling of the
isotype-matched control antibody specific for a cytosolic antigen
(Fig. 4A). By contrast, nucleolin-specific mAb bound to the surface
of HEp-2 cells treated with Stx2 for 2 h at a 2-fold or greater level
compared with untreated HEp-2 cells (Fig. 4A). This increase in
nucleolin surface expression was further enhanced by 24 h of
treatment with Stx2 that also corresponded with a dose-dependent
increase in cell death (Fig. 4A). This latter observation was not
unexpected; induction of apoptosis by Stx is a feature of intoxication
(16). To further substantiate this apparent Stx2-evoked increase in
surface-localized nucleolin, membrane-associated proteins were
prepared by high-salt extraction from epithelial cells treated with or
without Stx2 (100 ngml) for 2 h, and nucleolin was detected by
Fig. 1. Growth comparison, expression profiles, and characterization of cytotoxicity associated with WT EHEC and its stx2 isogenic mutant. (A) Growth curves
of strains 86-24 () and TUV86-2 (E) in Eagle’s minimal essential medium (EMEM) and LB. (B) Immunoblot evaluation of lysates of cultures of 86-24 or TUV86-2
for Stx2, intimin, and Tir. (C) Cytotoxic effects of serially diluted lysates of DH5 (‚), 86-24 (), TUV86-2 (E), or medium () alone on Vero cells after 48 h of
incubation.
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immunoblot. The immunodetection protocol revealed that epithe-
lial cells treated with Stx2 displayed an increase in nucleolin at the
cell surface (Fig. 4B) that was consistent with an augmentation of
TUV86-2 adherence in the presence of purified Stx2 (Fig. 2). In a
separate experiment, we demonstrated that HEp-2 cells treated
with the purified Stx2 toxoid that contained the E167D mutation
did not exhibit increased surface localization of nucleolin (Fig. 4C),
a finding that is consistent with the results depicted in Fig. 2B.
Discussion
Stx production by EHEC O157:H7 was linked to the development
of the life-threatening hemolytic uremic syndrome more than 2
decades ago (Stx was called Vero toxin in ref. 17). However, the
advantage, if any, that synthesis of Stx provides to this microbe that
normally resides in the bovine host without causing apparent illness
(2) remained a subject of speculation. Here, we sought to address
this issue by askingwhether Stx synthesismight aidEHECO157:H7
in establishing infection. We previously reported that nucleolin
interacts with intimin and is associated with sites of EHEC attach-
ment (9). Therefore, we reasoned that an Stx-mediated enhance-
ment of cell surface-localized nucleolinmight provide an adherence
advantage to toxin-producing EHEC O157:H7 strains. In this
report, we provide several lines of evidence to suggest that this
hypothesis is correct. Specifically, we show that epithelial cells
exposed to enzymatically active purified Stx2 exhibited increased
surface expression of nucleolin, that theWTEHECO157:H7 strain
86-24 did in fact adhere better to epithelial cells in tissue culture
than did its stx2 isogenic mutant, and that 86-24 colonized mice at
a higher level than did the isogenic mutant.
That Stx2 plays an important role in augmenting the adherence
of EHEC O157:H7 strain 86-24 was further demonstrated by the
finding that exposure of epithelial cells to Stx2 for 2 h before
infection and maintenance of toxin in tissue culture medium
throughout the infection enhanced the adherence levels of the stx2
isogenicmutant strain TUV86-2 to an even greater extent than that
of WT 86-24. The observation that the extent of TUV86-2 adher-
ence when Stx2 was added was greater than that of 86-24 might
reflect differences in toxin concentrations between the two types of
experiments (100 ngml in the complementation study and25–75
ngml in supernatants that contained WT bacteria during the
adherence assay) andor the pretreatment ofHEp-2 cells with toxin
that was necessary to fully restore adherence of the toxin-negative
mutant strain to at leastWT levels. The finding that Stx-neutralizing
antibody and an active site mutation abrogated this increased
Fig. 2. Quantitation of in vitro adherence to epithelial cells ofWT EHEC and its
stx2 isogenic mutant. Adherence to HEp-2 cells infected with GFP-expressing
bacteria was assessed by flow cytometry. Black bars represent the proportion of
HEp-2cells towhichany86-24orTUV86-2adhered(the infectedcellpopulations).
Gray hatched bars indicate the relative number of bacteria adhered to an indi-
vidual HEp-2 cell in the respective infected populations when compared with
86-24-infected samples (set at 1). Asterisks indicate statistical significance in the
95% confidence interval analyzed by ANOVA. (A) Purified Stx2 (100 ngml) was
added toHEp-2 cells in the presence or absence of anti-Stx2 neutralizingmAbor
normalmouse serum (NMS)where indicated. Findings for the additionof Stx2 or
antibodies show a single representative experiment performed in triplicate (n
3)  SE. Data for the negative control, 86-24, and TUV86-2 alone are the geo-
metricmeansof four individualexperimentsperformedintriplicate (n12)SE.
(B) Purified Stx2-6H or the E167D mutant derivative (100 ngml) was added to
HEp-2 cells where indicated as in A. Results shown correspond to a single repre-
sentative experiment performed in triplicate (n 3) SE.
Fig. 3. Comparison of the capacity of WT EHEC and its stx2 isogenic mutant
to colonize mice. (A) Single-strain challenges: BALBc mice were orally in-
fected twice with an inoculum that contained 2.5  109 cfu of 86-24 () or
TUV86-2 (E). On subsequent days after infection, fecal pellets were collected,
homogenized, and serially diluted for plating on MacConkey agar that con-
tained sorbitol. Results from each mouse and the geometric mean of 10 mice
infected with 86-24 (black line) or TUV86-2 (gray line) are presented. The
horizontal line represents the limit of detection. Asterisks below the x axis
indicate days in which a statistical difference (P  0.05) between strains was
established. (B)Mixed-strain challenge: BALBcmicewere orally infected as in
A with an inoculum that contained 2.5  109 cfu of 86-24 and TUV86-2 in
equal ratios. Individual colonies were differentiated by screening for an stx2
sequence or Stx2. The level of colonization reflected by each strain in an
individual mouse and the geometric mean of 10 mice are presented as in A.
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adherence supported the specificity of the toxin effect on bacterial
adherence. This enhancement of adherence by the addition of
enzymatically active Stx2 to the culture system paralleled the
Stx2-mediated increases in surface-expressed nucleolin (shown in
Fig. 4). From these data, we inferred that when epithelial cells were
exposed to Stx2, more nucleolin became localized at the cell
surface, and this increase allowed for greater intimin-driven EHEC
O157:H7 adherence.
The in vitro adherence assay is a useful system for evaluating the
specific steps in bacterial:host cell interactions but does not fully
reflect the conditions that must be overcome by the bacterium to
successfully attach to enterocytes in the intestinalmilieu. Therefore,
we compared the colonizing capacities of strain 86-24 with those of
TUV86-2 in conventionally bredmice that harbor normal intestinal
flora. When these animals were infected individually with these
bacteria, the Stx2-expressing WT strain colonized the animals to a
greater extent than did the stx2 isogenic mutant. When such mice
were infected with an inoculum that contained equivalent concen-
trations of 86-24 and TUV86-2, toxin produced from 86-24 ap-
peared to complement the colonization defect of TUV86-2. This
result was consistent with the capacity of purified Stx2 to augment
TUV86-2 adherence in vitro (Fig. 2).
Two reports in the literature contain data, albeit limited, that
support our contention that Stx expression positively impacts
EHEC O157:H7 colonization. First, in a signature-tagged mu-
tagenesis study aimed at identifying factors that influence coloni-
zation of the bovine gut, Dziva et al. (18) failed to recover a mutant
of the EHEC 0157:H7 strain EDL933 that contained a transposon
inserted into a gene located between the stx1 genes and bacterio-
phage genes involved in bacterial cell lysis. This observation was not
discussed in detail, nor was the toxin phenotype of that strain
described, but we would predict that Stx1 production or release
could likely be abrogated in such a mutant. Second, Sjogren et al.
(19) showed that the rabbit diarrheal pathogen E. coli strain
RDEC-1 transduced with an Stx1-converting bacteriophage caused
a more severe infection than did the nontransduced strain and also
noted that the transduced strain colonized rabbits 1–2 days earlier.
Because as few as 100 EHEC O157:H7 organisms are sufficient
to cause human disease (2), it seems unlikely that the concentration
of toxin produced from such a small number of bacteria would be
sufficient to alter the surface expression of nucleolin in the large
bowel during the initial attachment phase of infection. Thus, Stx2
may not provide a significant advantage for bacterial attachment in
the earliest stages of a low-dose infection of humans. Although
much higher doses of EHEC O157:H7 are required to establish
infection in mice, our general supposition that the impact of toxin
from the inoculum is not critical to initial colonization is in keeping
with our finding in single-strain mouse challenge experiments. In
those studies, 86-24 did not colonize demonstrably better than did
TUV86-2 during the first 2 days of infection. Thus, we propose that
only when EHEC is intimately attached to the intestinal epithelium
do subsequent progeny benefit from an increase in surface recep-
tors available for attachment. Although toxin produced during
infection is likely diffusible throughout the intestinal mucosa, we
suspect that, at specific regions of bacterial attachment and attach-
ing-and-effacing lesion formation, concentrations of toxin are tran-
sientlymuch higher than the net concentration throughout the large
bowel. Therefore, we hypothesize that, at local sites of adherence
where toxin concentration is expected to be higher, an environment
suited for enhanced adherence is created that stimulates the
enlargement of microcolonies. This prediction is supported by
adherence micrographs and quantitative results that typically show
microcolony formation to be more developed when epithelial cells
are infected with the toxin-producing strain.
Whether the effect of Stx2 on nucleolin surface localization is the
sole explanation for the clear benefit that toxin production plays in
the capacity of EHEC O157:H7 to adhere to epithelial cells and
colonize mice remains to be determined. We recognize that, in
addition to nucleolin, other eukaryotic proteins may also bind
intimin and promote bacterial adhesion. However, we have no
evidence as yet that the distribution of such theoretical intimin
receptors is affected by Stx. Moreover, a close association between
localization of nucleolin and adherent EHEC O157:H7 has been
demonstrated in the mouse intestine (20).
The details of the cellular mechanism involved in Stx-mediated
enhancement in surface-expressed nucleolin are still unknown.
Certainly, several explanations are possible. One particularly ap-
pealing idea is that the increase in nucleolin at the cell surface that
Fig. 4. Quantification of nucleolin surface expression
on epithelial cells after exposure to Stx2 or Stx2 toxoid.
(A) HEp-2 cells were treated with or without Stx2 at
indicated concentrations for 2 (■) or 24 () h. Surface-
expressed proteins were labeled with monoclonal iso-
type-matched control or a nucleolin-specific antibody.
The results were normalized by expressing values corre-
sponding toall samplegroups relative tountreatedcells.
Data presented are arithmetic means  SE from a rep-
resentative experiment with samples performed in trip-
licate. Asterisks above Stx2-treated sample groups indi-
cate statistical difference in the 95%confidence interval
from the untreated control within a time series estab-
lishedbyindependentsample t tests; samplegroupswith
an equivalent number of asterisks are not significantly
different fromeachother. (B)HEp-2cellswereuntreated
(Untr)or treatedwith100ngmlStx2for2h.Membrane-
associatedproteinswereextracted indetachmentbuffer
that contained 1 M NaCl for 2 min on ice. Membrane-
associated proteins were separated by SDSPAGE and
stained with silver (Upper) or subjected to immunoblot-
ting with nucleolin-specific mAb (Lower). Immunola-
beledbanddensities expressed relative to theuntreated
control were quantifiedwith IMAGE J software. (C) HEp-2
cells were treatedwith or without Stx2-6H or the E167D
mutatedderivative(100ngml)for2or24h,andsurface-
expressed proteins were labeled with monoclonal iso-
type-matched control or a nucleolin-specific antibody.
Data are presented as in A.
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is reported here might be part of a stress response to intoxication
and a pre-apoptotic mechanism. Indeed, increased surface expres-
sion of nucleolin has also been described in leukemia cells under-
going apoptosis (21). However, it is also noteworthy that nucleolin
and Stx share an affinity for the same substrate, ribosomal RNA.
Thus, it is conceivable that there is a directmechanistic link between
the Stx mode of action and an increase in surface expression of
nucleolin.
Materials and Methods
Strains, Antibodies, and Primers. EHEC O157:H7 strain 86-24 and
EHECO157:H7 strain TUV86-2, an isogenic stx2 mutant, are both
nalidixic acid resistant and were kindly provided by A. Donahue-
Rolfe (13). Antibodies used in this study were mouse monoclonal
anti-nucleolin C23 (MS-3; Santa Cruz Biotechnology), mouse
monoclonal anti-glyceraldehyde phosphate dehydrogenase (Santa
Cruz Biotechnology), mouse monoclonal anti-intimin- EE4IIE2
(9), rabbit polyclonal anti-Tir (9), mouse monoclonal anti-Stx2
11E10 (22), mouse monoclonal anti-Stx2 BC5 (ref. 23; kindly
provided by Nancy Strockbine, Centers for Disease Control and
Prevention, Atlanta), horseradish peroxidase (HRP)-conjugated
goat anti-mouse IgG (Bio-Rad), and HRP-conjugated goat anti-
rabbit IgG (Bio-Rad). The PCRprimers used in this study are listed
in Table 1, which is published as supporting information on the
PNAS web site.
Colony PCR. PCR performed directly from bacterial colonies lysed
in sterile water at 95°C for 5 min was performed in a 50-l reaction
that contained 5 l of lysed bacterial suspension, 50 mM TrisHCl
(pH 8.3), 10 mM KCl, 5 mM [NH4]2SO4, 2 mM MgCl2, 1 M
forward and reverse primers, 0.4 mM dNTPs, and FastStart
TaqDNA polymerase (2 units; Roche Applied Science, Indianap-
olis). Reaction cycling was done in a PTC-150 Minicycler (MJ
Research, Cambridge, MA).
Construction of Stx2-6-His Tag and Protein Purification. The plasmid
construct pMJS50 that permitted expression of Stx2 with a C-
terminal 6-histidine tag on the B subunit (designated Stx2-6H), was
generated by consecutive rounds of PCR by standard techniques.
Initially, amplification from pMJS2 (24) was done with primers
2A51 and C12B. Subsequent PCRs were performed with primer
pairs 2A52 and C22B, followed by 2A52 and BC3. The final
amplicon included an optimized Shine–Dalgarno sequence up-
stream of the stxA2 gene and was ligated into the expression vector
pTrcHis2C (Invitrogen). The E167D mutation was generated in
pMJS50 (creating pCMR1) by internal ligation after restriction at
a common NsiI site of PCR fragments amplified with the primer
pairs TRC-F and 167R for the upstream fragment or 167-F and
TRC-R for the downstream fragment. The purification of Stx2-6H
and Stx2(E167D)-6H from E. coli L172 (25) was done by nickel-
affinity column chromatography (Qiagen, Valencia, CA), essen-
tially according to themanufacturer’s instructions. Stx2was purified
by affinity chromatography as described in ref. 26 by using 11E10
mAb.
Vero Cell Cytotoxicity Assay. The cytotoxic activity for Vero cells of
clarified bacterial lysates or adherence assay culture supernatants
that contained Stx2, Stx2-6H, or Stx2(E167D)-6H or purified
preparations of these proteins was determined as detailed in ref. 24.
Bacterial Adherence Assay. HEp-2 cells were maintained in com-
plete Eagle’s minimal essential medium (EMEM) at 37°C in 5%
CO2. Plasmid pEGFP (Clontech) was electroporated into EHEC
O157:H7 strain 86-24 and EHEC O157:H7 strain TUV86-2 that
had been made competent by standard techniques. EHEC strains
were grown statically to stationary phase in LB supplemented with
ampicillin (100 gml), nalidixic acid (25 gml), and isopropyl-
-D-thiogalactopyranoside (IPTG) (2 mM) at 37°C. Subconfluent
monolayers of HEp-2 cells cultured in 12-well dishes (for flow
cytometric analysis; Costar and Corning) or 8-well chamber slides
(for microscopic analysis; Lab-Tek and Nalge Nunc) were infected
at a multiplicity of infection of 50 (bacteria to epithelial cell) in
adherence medium [EMEM supplemented with L-glutamine (2
mM)sodium bicarbonate (0.4%)D-mannose (1%)ampicillin
(100 g/ml)nalidixic acid (25 g/ml)IPTG (2 mM)] for 6 h.
Supernatants from uninfected controls and infected cultures were
saved for evaluation of toxicity toward Vero cells and for the
presence of Stx2 protein by immunoblot.
For flow cytometric analysis, HEp-2 cells were washed exten-
sively with PBS and harvested by treatment with 0.25% trypsin
(Cambrex, EastRutherford,NJ). Intimate adherence ofEHECwas
not sensitive to the activity of trypsin. HEp-2 cells were suspended
in PBS that contained 3% formalin, and fluorescent intensity for
10,000 gated events was quantified with an EPICS XL-MCL flow
cytometer in the FL-1 channel. For experiments that included the
addition of purified toxin, Stx2, Stx2-6H, or Stx2(E167D)-6H (100
ngml) was added to HEp-2 cells with or without equivalently
diluted BC5 (mouse monoclonal Stx2 neutralizing antiserum) or
normal mouse serum for 2 h before infection and maintained
throughout the assay. For microscopic analysis, individual wells of
chamber plates were washed extensively with PBS and fixed with
PBS that contained 3.7% paraformaldehyde for 10 min. The
epithelial cells were then permeabilized with 0.1%TritonX-100 for
5 min and blocked for 30 min with PBS containing 1% BSA. The
epithelial cells were then stained with Alexa Fluor 594 phalloidin
(Molecular Probes) diluted in PBS that contained 1% BSA for 20
min at room temperature. Slides were examined with a BX60
microscope (Olympus, Melville, NY) fitted with a BX-FLA re-
flected light fluorescence attachment. The images presented here
were obtained with a SPOT RT charge-coupled device digital
camera (Diagnostic Instruments, Sterling Heights, MI)
Mouse Infection. Six-week-old BALBc mice (Charles River Lab-
oratories)were fasted for18h anddeprived ofwater for 4 h before
infection. Cultures (100 ml) of EHEC O157:H7 strain 86-24 and
O157:H7 strain TUV86-2 were grown in LB at 37°C overnight with
aeration and then concentrated 50-fold in PBS that contained 20%
sucrose. For single-strain experiments, five mice were fed 50 l of
solution that contained 2.5  109 cfu of EHEC O157:H7 strain
86-24 or EHEC O157:H7 strain TUV86-2 followed by a second
feeding 2 h later. The experimentwas repeated, and the results from
the two studies were combined for a total of 20 mice (10 animals
per strain). For mixed-strain studies, five mice were fed 50 l of
solution that contained 2.5  109 cfu composed of equivalent
amounts of EHEC O157:H7 strain 86-24 and EHEC O157:H7
strain TUV86-2. Two such mixed-strain experiments were done,
and the data from the 5 animals per study were combined for a total
of 10 doubly infected mice. Fecal pellets were collected on subse-
quent days, homogenized in sterile PBS to create an initial 10-fold
dilution (wtvol), and serially diluted for plating on sorbitol Mac-
Conkey agar supplemented with nalidixic acid (25 gml). Indi-
vidual sorbitol-fermenting colonies that grew after overnight incu-
bation at 37°C were enumerated. For the mixed infection, colonies
that grew on sorbitol MacConkey agar were patched onto LB agar
that contained nalidixic acid (25 gml) for differentiation accord-
ing to stx2 sequence (by colony blot) or Stx2 production (by dot
blot). When necessary, results were confirmed by colony PCR with
the primer pair UB-3 and CR-1398 (Table 1). These primers
generate amplification products from 86-24 and TUV86-2 that
differ in size by 589 bp because of the deleted sequence in
TUV86-2.
Colony Blots.Colonies were lifted onto nylonmembranes (Hybond-
N; Amersham Pharmacia Biosciences) that were subsequently
placed upright on filter paper soaked in 0.5 M NaOH for 5 min.
Nylon membranes were then washed twice in 5 SSC (75 mM
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Na3C6H5O70.75 M NaCl, pH 7) and air-dried, and the DNA was
crosslinked to the membrane by exposure to UV light. The 517-bp
DNA probe was generated by colony PCR with the primer pair
TUVdel-F and TUVdel-R specific for the regions of the stx2AB
genes deleted in TUV86-2. This probe was purified by agarose gel
electrophoresis and then labeled with HRP (ECL direct nucleic
acid labeling system; Amersham Pharmacia Biosciences) according
to the manufacturer’s instructions. The labeled probe (200 ng per
membrane) was then added directly to hybridization buffer (ECL
Gold; Amersham Pharmacia Biosciences) that had been preincu-
bated with the membrane for 1 h at 42°C. The probe in hybridiza-
tion buffer and the membrane were then incubated at 42°C
overnight with gentle shaking. Each membrane was then rinsed
twice in primary wash buffer (6 M urea0.4% SDS0.5 SSC) for
20 min at 42°C and twice in secondary wash buffer (2 SSC) for
5 min at room temperature. Hybridized probe was detected by
enhanced chemiluminescence (ECL direct nucleic acid labeling
system).
Dot Blots. Each colony was inoculated into a microfuge tube that
contained LB with nalidixic acid (25 gml) and grown overnight
at 37°C. The tubes were then centrifuged at 4,000 g for 5min, and
200 l of supernatant was vacuum-filtered onto nitrocellulose
membranes (Schleicher & Schuell) by using a Minifold I micro-
sample filtrationmanifold (Schleicher&Schuell).Membraneswere
blocked in Tris-buffered saline that contained 5% nonfat dry milk
and 3%BSAovernight at 4°C and then probedwith the 11E10mAb
specific for the Stx2 A polypeptide as described below.
ELISA-Based Quantification of Nucleolin Surface Expression on Epi-
thelial Cells. HEp-2 cells (105 per well) cultured in 24-well dishes
were washed with Hanks’ balanced salt solution (BioWhittaker)
and replaced with adherence medium with or without purified Stx2
at indicated concentrations. Cultures were incubated at 37°C in 5%
CO2 for a total of 2 or 24 h. For the last hour of incubation,
anti-nucleolin mAb C23 or anti-glyceraldehyde phosphate dehy-
drogenasemAb as an isotype-matched irrelevant control was added
directly to appropriate wells. Surface-bound primary antibody was
detected withHRP-conjugated goat anti-mouse IgG diluted in PBS
with 3% BSA and visualized with TMB Peroxidase E1A substrate
(Bio-Rad). Optical density (at 600 nm) for each well was measured
and recorded with an ELx800 microplate reader. The colorimetric
solution was then aspirated, and the formalin-fixed epithelial cells
were stained with a solution that contained 0.13% (wtvol) crystal
violet and 5% ethanol to account for potential differences in cell
density after 24 h of exposure to toxin.
Detachment of Membrane-Associated Proteins from Intact Cells.
Membrane-associated proteins were prepared as described in ref.
27 with minor modifications. Briefly, HEp-2 cells (2 107) seeded
to subconfluency in T75 flasks were washed with Hanks’ balanced
salt solution that was replaced with adherence medium with or
without purified Stx2 (100 ngml) for 2 h.Mediawere removed, and
the cells were washed with PBS. Detachment buffer (1 ml) (20 mM
phosphate buffer, pH 7.5500 mM L-proline1 M NaCl0.5 mM
EDTA10 g/ml each aprotinin, leupeptin, and pepstatin A) was
added for 2 min to each flask kept on ice. Flasks were tilted to
collect the contents, and the solutions were clarified by centrifu-
gation for 5 min at 200  g at 4°C. Supernatants that contained
membrane-associated proteins detached from the cell surface were
collected and dialyzed in PBS overnight at 4°C. Dialysates were
concentrated with Centricon concentrators (10-kDa molecular-
mass cutoff; Amicon Bioseparations). Cell integrity was evaluated
by monitoring for the presence of lactate dehydrogenase activity
according to the manufacturer’s instructions (LDH cytoxicity kit;
Roche Diagnostics) in both the extraction supernatant and con-
centrated dialysates.
Immunoblot Analysis. Proteins were separated by molecular weight
according to standard techniques by SDSPAGE. Proteins were
transferred to nitrocellulose membranes with a TransBlot SD
SemiDry Electrophoretic Transfer Cell (Bio-Rad). Membranes
were blocked in PBS that contained 5% powdered milk, 1% BSA,
and 0.05% Tween 20. Primary and secondary antibodies were
diluted in the same solution. Immunolabeled proteins were de-
tected by enhanced chemiluminescence (ECL Plus; Amersham
Pharmacia Biosciences).
Statistical Analysis. For single-strain challenge mouse studies, re-
peated measures ANOVA with bacterial strain as a between-
subjects factor and day as a within-subjects factor was used to assess
any statistically significant (at P 0.05) differences in colonization
levels between 86-24 and TUV86-2. Independent sample t tests
were used to establish statistical significance at P  0.05 in
colonization levels between bacterial strains for each day repre-
sented in the single-strain challenge mouse infection. For the dual
strain challenge mouse infections, a mixed model for repeated
measures ANOVAwith strain and day as within-subject factors was
used to define any statistically significant (at P  0.05) differences
in colonization between bacterial strains. Paired sample t tests were
used to analyze statistical significance at P  0.05 in colonization
levels between bacterial strains for each day represented in these
mixed-strain studies. For quantitative bacterial adherence toHEp-2
cell assays, ANOVA was used to analyze the statistical significance
of differences among geometric means of triplicate samples from
four individual experiments. For the quantification of nucleolin
surface expression, independent sample t tests were used to eval-
uate statistical significance (P  0.05) of the fold change.
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